Jason Rando | Tiberend Strategic Advisors |
Travis Mickle | President and CEO |
LaDuane Clifton | CFO |
Jonathan Aschoff | ROTH Capital Partners |
Thank you for standing by, and welcome to KemPharm Fourth Quarter and Year-End 2021 Results Conference Call. [Operator Instructions] Please be advised that today's conference may be recorded. [Operator Instructions] I would now like to hand the call over to Jason Rando of Tiberend Strategic Advisors.
Good afternoon, and thank you for joining our call today to discuss KemPharm's fourth quarter and full year 2021 financial and corporate results.
Before we begin, I would like to remind our listeners that remarks made during this call may contain forward-looking statements that involve risks and uncertainties and are subject to changes at any time, including but not limited to statements about KemPharm's expectations regarding future operating results.